UM

Browse/Search Results:  1-10 of 25 Help

Selected(0)Clear Items/Page:    Sort:
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma Journal article
Wang, Weidong, Lv, Wang, Wang, Hui, Xu, Yang, Yan, Junrong, Shen, Han Ming, Shan, Liqun, Hu, Jian. A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma[J]. Genes and Diseases, 2023, 10(6), 2241-2244.
Authors:  Wang, Weidong;  Lv, Wang;  Wang, Hui;  Xu, Yang;  Yan, Junrong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.9/7.2 | Submit date:2024/01/10
Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment Journal article
Li,Guodong, Huang,Qi, Wai Wong,Vincent Kam, Wang,Wanhe, Leung,Chung Hang. Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment[J]. Genes and Diseases, 2023, 10(6), 2260 - 2262.
Authors:  Li,Guodong;  Huang,Qi;  Wai Wong,Vincent Kam;  Wang,Wanhe;  Leung,Chung Hang
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:6.9/7.2 | Submit date:2023/08/03
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma Other
2023-04-24
Authors:  Weidong Wang;  Wang Lv;  Hui Wang;  Yang Xu;  Junrong Yan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date:2023/08/03
Etiological roles of core promoter variation in triple-negative breast cancer Journal article
Huang, Teng, Li, Jiaheng, Wang, San Ming. Etiological roles of core promoter variation in triple-negative breast cancer[J]. Genes & Diseases, 2023, 10(1), 228 - 238.
Authors:  Huang, Teng;  Li, Jiaheng;  Wang, San Ming
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:6.9/7.2 | Submit date:2022/05/17
Core Promoter  Rna-seq  Triple-negative Breast Cancer  Variation  Whole Exome Sequencing  
NR2F2 Regulates Cell Proliferation and Immunomodulation in Whartons’ Jelly Stem Cells Journal article
Ma, Li, Huang, Min, Liao, Xiaohua, Cai, Xiyu, Wu, Qiang. NR2F2 Regulates Cell Proliferation and Immunomodulation in Whartons’ Jelly Stem Cells[J]. Genes, 2022, 13(8).
Authors:  Ma, Li;  Huang, Min;  Liao, Xiaohua;  Cai, Xiyu;  Wu, Qiang
Favorite | TC[WOS]:4 TC[Scopus]:3  IF:2.8/3.3 | Submit date:2023/01/30
Cell Cycle  Gene Regulatory Network  Immunomodulation  Nr2f2  Rna-seq  Wj-mscs  
Ablation of Ghrelin Receptor Mitigates the Metabolic Decline of Aging Skeletal Muscle Journal article
O’Reilly, Colleen, Lin, Ligen, Wang, Hongying, Fluckey, James, Sun, Yuxiang. Ablation of Ghrelin Receptor Mitigates the Metabolic Decline of Aging Skeletal Muscle[J]. Genes, 2022, 13(8), 1368.
Authors:  O’Reilly, Colleen;  Lin, Ligen;  Wang, Hongying;  Fluckey, James;  Sun, Yuxiang
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:2.8/3.3 | Submit date:2023/01/30
Aging  Ghs-r  Irisin  Skeletal Muscle  
Development of an orally bioavailable selective inhibitor of the menin-MLL Journal article
Zhong, Hai Jing, Wang, Wanhe, Zhou, Wei, Liang, Jia Xin, Cheng, Yung Chi, Ma, Dik Lung, Leung, Chung Hang. Development of an orally bioavailable selective inhibitor of the menin-MLL[J]. Genes and Diseases, 2022, 10(5), 1735-1738.
Authors:  Zhong, Hai Jing;  Wang, Wanhe;  Zhou, Wei;  Liang, Jia Xin;  Cheng, Yung Chi; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:6.9/7.2 | Submit date:2023/01/30
The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications Journal article
Huang, Dan, Liu, Gege, Xu, Zhiyi, Chen, Shushu, Wang, Cuili, Liu, Dewei, Cao, Jiahao, Cheng, Junfen, Wu, Bin, Wu, Dong. The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications[J]. Genes and Diseases, 2022.
Authors:  Huang, Dan;  Liu, Gege;  Xu, Zhiyi;  Chen, Shushu;  Wang, Cuili; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4 | Submit date:2023/01/30
AHR  Airway remodeling  Bronchial asthma  Chronic airway inflammation  PlGF  
Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells Journal article
Shasha Cheng, Guan-Jun Yang, Wanhe Wang, Dik-Lung Ma, Chung-Hang Leung. Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells[J]. Genes & Diseases, 2021, 9(6), 1674-1688.
Authors:  Shasha Cheng;  Guan-Jun Yang;  Wanhe Wang;  Dik-Lung Ma;  Chung-Hang Leung
Favorite | TC[WOS]:24 TC[Scopus]:27  IF:6.9/7.2 | Submit date:2022/05/13
Cancer Stem Cells  Cdk9-cyclin T1  Epithelial Mesenchymal Transition  Protein–protein Interaction (Ppi)  Triple-negative Breast Cancer (Tnbc)  
RSU-1 maintains integrity of caenorhabditis elegans vulval muscles by regulating a-actinin Journal article
Wang,Xinyan, Huang,Shuai, Zheng,Cunni, Ge,Wei, Wu,Chuanyue, Tse,Yu Chung. RSU-1 maintains integrity of caenorhabditis elegans vulval muscles by regulating a-actinin[J]. G3: Genes, Genomes, Genetics, 2020, 10(7), 2507-2517.
Authors:  Wang,Xinyan;  Huang,Shuai;  Zheng,Cunni;  Ge,Wei;  Wu,Chuanyue; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:2.1/2.5 | Submit date:2021/03/02
A-actinin  Egg-laying  Ras  Rsu-1  Vulval Muscle Cells